Evidence map›Paper›PMID 36340319›Full record

ArticleJournal of clinical and experimental hepatology

Clinical Profile, Patterns of Care & adherence to Guidelines in Patients with Hepatocellular Carcinoma: Prospective multi-center Study.

Akash Shukla, Shraddha Patkar, Sridhar Sundaram, Samir R Shah, Meghraj Ingle, Amit Gupta, Amrit Gopan, Mrunal Kamat, Ravi Mohanka, Sandeep Singh and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical and experimental hepatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Akash ShuklaDepartment of Gastroenterology, Seth G.S Medical College and King Edward Memorial Hospital, Mumbai, India.
Shraddha PatkarDepartment of Surgical Oncology, Tata Memorial Hospital, Mumbai, India.
Sridhar SundaramDepartment of Gastroenterology, Seth G.S Medical College and King Edward Memorial Hospital, Mumbai, India.
Samir R ShahDepartment of Hepatology, Institute of Liver Disease, Hepato-pancreatico-biliary Surgery and Transplant, Global Hospitals, Mumbai, India.
Meghraj IngleDepartment of Gastroenterology, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, India.
Amit GuptaDepartment of Surgical Oncology, Tata Memorial Hospital, Mumbai, India.
Amrit GopanDepartment of Gastroenterology, Seth G.S Medical College and King Edward Memorial Hospital, Mumbai, India.
Mrunal KamatDepartment of Hepatology, Institute of Liver Disease, Hepato-pancreatico-biliary Surgery and Transplant, Global Hospitals, Mumbai, India.
Ravi MohankaDepartment of Hepatology, Institute of Liver Disease, Hepato-pancreatico-biliary Surgery and Transplant, Global Hospitals, Mumbai, India.
Sandeep SinghDepartment of Hepatology, Institute of Liver Disease, Hepato-pancreatico-biliary Surgery and Transplant, Global Hospitals, Mumbai, India.
Swapnil WalkeDepartment of Gastroenterology, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, India.
Vikas PandeyDepartment of Gastroenterology, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, India.
Mahesh GoelDepartment of Surgical Oncology, Tata Memorial Hospital, Mumbai, India.
Global Hospitals · INKing Edward Memorial Hospital and Seth G.S. Medical College · INLokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College · INTata Memorial Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: Increasing incidence of hepatocellular carcinoma (HCC) in India is a matter of concern and need for adequate profiling and streamlining management strategies cannot be over-emphasized. Methods: This is a prospective multi-centric observational cohort study comprising of an oncology center, one university tertiary hospital with specialized hepatology service, one public hospital with gastroenterology service, and a private liver transplant center located within a 3-km radius. The demographic and clinical parameters were recorded on a prospectively maintained database. The clinical profile, demographics, characteristics of HCC and the allocated treatment were noted and compared among the four centers. Results: In total, 672 patients were enrolled from June 2016 till January 2020. Abdominal pain (64.3%) and weight loss (47.3%) were the most common symptoms. Most common identified etiology was hepatitis B (39%). The cancer center received lesser patients with hepatitis C and those with advanced stage of HCC. The private transplant center reported the highest proportion of NASH, which was also significantly higher in those belonging to higher socioeconomic strata, and lowest proportion of alcoholic cirrhosis. Metastasis was seen in almost one-fifth (19%) cases at diagnosis. Portal vein thrombosis was evident in 40%. Adherence to treatment guidelines was seen in three-fourth cases (76%). Conclusions: Hepatitis B is the most common underlying cause for HCC, whereas other causes like NASH are on the rise. Etiologic profile may vary with selective specialization of centers catering to patients with HCC. Adherence to guideline while allocating treatment was high among all centers with highest non-adherence in BCLC A.

Indexed as

AASLD, American Association of Study of Liver DiseaseAFP, Alpha fetoproteinALP, Alkaline phosphataseALT, Alanine transaminaseAST, Aspartate transaminaseBCLC, Barcelona Clinic Liver Cancer stagingBCS, Budd Chiari syndromeclinical profileCT, Computed tomographyEASL, European Association for Study of LiverGGT, Gamma glutamyl transpeptidaseHBV, Hepatitis B virusHCC, Hepatocellular carcinomaHCV, Hepatitis C virushepatocellular carcinomaHKLC, Hong-Kong Liver Cancer stagingHVPG, Hepatic venous pressure gradientINR, International normalized ratioMDT, Multidisciplinary teammilan criteriaMRI, Magnetic resonance imagingmulticenterNAFLD, Non-alcoholic fatty liver diseasePHT, Portal hypertensionPVTT, Portal venous tumor thrombosis

Identifiers

PMID36340319
PMCPMC9630010
OpenAlexW4282053875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.